Premium
Low‐dose weekly methotrexate used to treat cutaneous Rosai–Dorfman disease
Author(s) -
Subash J. J.,
Kesty C.,
Kesty K. R.,
Asgari M.,
Jorizzo J.
Publication year - 2018
Publication title -
clinical and experimental dermatology
Language(s) - Uncategorized
Resource type - Journals
SCImago Journal Rank - 0.587
H-Index - 78
eISSN - 1365-2230
pISSN - 0307-6938
DOI - 10.1111/ced.13665
Subject(s) - methotrexate , medicine , rosai–dorfman disease , dermatology , disease , surgery
Click here for the corresponding questions to this CME article.